ScreenPoint Medical Acquires Biomediq A/S
January 8, 2025
ScreenPoint Medical has acquired Biomediq A/S to integrate Biomediq's quantitative imaging biomarkers and mammographic texture-risk model into ScreenPoint's Transpara breast-AI platform. The acquisition brings automated 2D/3D mammogram risk-analysis capabilities and the lead author of a related Radiology study, Andreas D. Lauritzen, will join ScreenPoint to accelerate development.
- Buyers
- ScreenPoint Medical
- Targets
- Biomediq A/S
- Industry
- Medical Devices
- Location
- Capital Region of Denmark, Denmark
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Premier Biotech Acquires NexScreen and TransMed
June 19, 2026
Healthcare Services
Premier Biotech (backed by Align Capital Partners) announced the acquisitions of NexScreen and TransMed to expand its drug and alcohol testing diagnostic product portfolio and global footprint. The deals add NexScreen’s point-of-care diagnostic testing presence in Australia and New Zealand and TransMed’s drug testing product catalog, e-commerce platform, and direct customer base.
-
Premier Biotech Acquires NexScreen and TransMed
June 18, 2026
Healthcare Services
Align Capital Partners-backed Premier Biotech announced the acquisitions of NexScreen and TransMed to expand its product portfolio, e-commerce capabilities, and global footprint. NexScreen adds point-of-care diagnostic testing presence in Australia and New Zealand, while TransMed strengthens Premier’s catalog and online distribution to 1,000+ direct customer accounts.
-
ThetaRay Acquires Screena
July 30, 2024
AI & Machine Learning
ThetaRay has acquired European AI-driven screening specialist Screena to integrate next-generation name screening and entity resolution into its cloud-based financial crime detection platform. The deal expands ThetaRay's capabilities across transaction monitoring, screening, and customer risk assessment, strengthening its offering to banks, fintechs and regulators.
-
EQT Acquires Majority Stake in CluePoints
June 12, 2024
AI & Machine Learning
EQT (via its Healthcare Growth strategy and the EQT Growth Fund) has agreed to acquire a majority stake in CluePoints, a Belgium-headquartered provider of AI-powered RBQM and clinical trial data analytics software. Existing investors Summit Partners and Clinimetrics SA (and management) will reinvest; the deal is intended to support CluePoints' continued product development, global expansion and entry into adjacent markets and is expected to close in Q3 2024.
-
Intelerad Acquires PenRad Technologies, Inc.
August 16, 2022
Healthcare Services
Intelerad Medical Systems has acquired PenRad Technologies, Inc., a provider of breast imaging, lung screening and patient-tracking software, to expand its mammography and lung analytics capabilities and optimize radiologist workflows. The deal follows Intelerad’s recent investment from TA Associates and aims to integrate PenRad’s solutions into Intelerad’s enterprise imaging platform to meet rising oncology screening demand.
-
Bioclinica Acquires Saliency to Accelerate Medical Imaging AI
January 6, 2021
AI & Machine Learning
Bioclinica, a Princeton, New Jersey-based clinical life science solutions provider, has acquired Silicon Valley-based Saliency to embed the startup's medical imaging AI into Bioclinica’s Imaging Platform. The acquisition is intended to accelerate image quality control and interpretation for pharmaceutical and medical device clients, enabling faster development of digital diagnostics and digital therapeutics.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.